Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.
|
Int J Antimicrob Agents
|
2004
|
2.21
|
2
|
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.
|
Antimicrob Agents Chemother
|
1997
|
1.87
|
3
|
Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
|
Antimicrob Agents Chemother
|
1998
|
1.79
|
4
|
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.
|
Antimicrob Agents Chemother
|
1996
|
1.34
|
5
|
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
|
Antimicrob Agents Chemother
|
1996
|
1.18
|
6
|
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
|
Antimicrob Agents Chemother
|
1996
|
1.01
|
7
|
Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.
|
Antimicrob Agents Chemother
|
1998
|
0.79
|
8
|
Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
1995
|
0.77
|